Skip to contentR
Rockwell Medical, Inc.
R
RMTIRockwell Medical, Inc. Q3 2023 · 10-Q
Revenue$23.77M$23.77M+27.2% vs Q3 2022 Net Income-$1.87M-$1.87MN/M vs Q3 2022 EPS Diluted-$0.07-$0.07N/M vs Q3 2022 Gross Profit$2,202,000+183.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rockwell Medical, Inc. · CIK 1041024 · Engraved from SEC EDGAR
Operating Cash Flowderived-$3,753,000N/M Margins · derivedGross margin9.3%+5.1 pt vs Q3 2022
Operating margin-7.3%+12.5 pt vs Q3 2022
Net margin-7.9%+14.5 pt vs Q3 2022
ended Sep 30, 2023 · filed Nov 14, 2023 · 45 d after period end